-transparent.png){kind=logo}
The effects of the acute and continued administration of the calcium antagonist nisoldipine on hepatic and renal blood flow and on renal function were studied in nine normotensive volunteers. There were no significant changes in supine blood pressure or heart rate but acute administration significantly increased both apparent liver blood flow and effective renal plasma flow. With continued administration these increases were attenuated and were not significantly different from placebo after 4 days treatment. Acute nisoldipine administration was also associated with significant increases in glomerular filtration rate and urinary sodium excretion.
Related Publications
P A Meredith, and
F Pasanisi, and
H L Elliott, and
J L Reid
December 1978,
Voprosy okhrany materinstva i detstva,
P A Meredith, and
F Pasanisi, and
H L Elliott, and
J L Reid
July 1984,
Gut,
P A Meredith, and
F Pasanisi, and
H L Elliott, and
J L Reid
May 1983,
British journal of clinical pharmacology,
P A Meredith, and
F Pasanisi, and
H L Elliott, and
J L Reid
October 1991,
American journal of veterinary research,
P A Meredith, and
F Pasanisi, and
H L Elliott, and
J L Reid
February 1998,
American journal of hematology,
P A Meredith, and
F Pasanisi, and
H L Elliott, and
J L Reid
February 1989,
Hepatology (Baltimore, Md.),
P A Meredith, and
F Pasanisi, and
H L Elliott, and
J L Reid
June 1981,
Polski tygodnik lekarski (Warsaw, Poland : 1960),
P A Meredith, and
F Pasanisi, and
H L Elliott, and
J L Reid
January 1982,
European journal of nuclear medicine,
P A Meredith, and
F Pasanisi, and
H L Elliott, and
J L Reid
January 1972,
Progress in nuclear medicine,
P A Meredith, and
F Pasanisi, and
H L Elliott, and
J L Reid
January 1983,
Clinical pharmacology and therapeutics,
